Suppr超能文献

左心室血栓的管理:一篇叙述性综述。

Management of left ventricular thrombus: a narrative review.

作者信息

Cruz Rodriguez Jose B, Okajima Kazue, Greenberg Barry H

机构信息

Division of Cardiovascular Diseases, Texas Tech University Health Science Center, El Paso, TX, USA.

Heart Failure/Cardiac Transplantation Program, University of California, San Diego, CA, USA.

出版信息

Ann Transl Med. 2021 Mar;9(6):520. doi: 10.21037/atm-20-7839.

Abstract

Left ventricular thrombus (LVT) is a serious complication of acute myocardial infarction (MI) and also non-ischemic cardiomyopathies. We performed a narrative literature review, manual-search of reference lists of included articles and relevant reviews. Our literature review indicates that the incidence of LVT following acute MI has decreased, probably due to improvement in patient care as a result of better and earlier reperfusion techniques. Predictors of LVT include anterior MI, involvement of left ventricular (LV) apex (regardless of the coronary territory affected), LV akinesis or dyskinesis, reduced LV ejection fraction (LVEF), severe diastolic dysfunction and large infarct size. LVT is associated with increased risk of systemic embolism, stroke, cardiovascular events and death, and there is evidence that anticoagulant therapy for at least 3 months can reduce the risk of these events. Cardiac magnetic resonance (CMR) has the highest diagnostic accuracy for LVT, followed by echocardiography with the use of echocardiographic contrast agents (ECAs). Although current guidelines suggest use of vitamin K antagonist (VKA) for a minimum of 3 to 6 months, there is growing evidence of the benefits of direct acting oral anticoagulants in treatment of LVT. Embolic events appear to occur even after resolution of LVT suggesting that anticoagulant therapy needs to be considered for a longer period in some cases. Recommendations for the use of triple therapy in the presence of the LVT are mostly based on extrapolation from outcome data in patients with atrial fibrillation (AF) and MI. We conclude that the presence of LVT is more likely in patients with anterior ST-segment elevation MI (STEMI) (involving the apex) and reduced ejection fraction (EF). LVT should be considered a marker of increased long-term thrombotic risk that may persist even after thrombus resolution. Ongoing clinical trials are expected to elucidate the best management strategies for patients with LVT.

摘要

左心室血栓(LVT)是急性心肌梗死(MI)以及非缺血性心肌病的严重并发症。我们进行了一项叙述性文献综述,手动检索了纳入文章的参考文献列表及相关综述。我们的文献综述表明,急性心肌梗死后LVT的发生率有所下降,这可能是由于更好、更早的再灌注技术使患者护理得到改善。LVT的预测因素包括前壁心肌梗死、左心室(LV)心尖受累(无论受影响的冠状动脉区域如何)、LV运动减弱或运动障碍、左心室射血分数(LVEF)降低、严重舒张功能障碍和大面积梗死灶。LVT与全身栓塞、中风、心血管事件和死亡风险增加相关,并且有证据表明至少3个月的抗凝治疗可降低这些事件的风险。心脏磁共振成像(CMR)对LVT的诊断准确性最高,其次是使用超声心动图造影剂(ECA)的超声心动图检查。尽管当前指南建议使用维生素K拮抗剂(VKA)至少3至6个月,但越来越多的证据表明直接口服抗凝剂在治疗LVT方面具有益处。即使LVT溶解后仍可能发生栓塞事件,这表明在某些情况下需要考虑更长时间的抗凝治疗。在LVT存在的情况下使用三联疗法的建议大多基于对房颤(AF)和心肌梗死患者结局数据的推断。我们得出结论,前壁ST段抬高型心肌梗死(STEMI)(累及心尖)且射血分数(EF)降低的患者更易出现LVT。LVT应被视为长期血栓形成风险增加的标志物,即使血栓溶解后该风险仍可能持续存在。正在进行的临床试验有望阐明LVT患者的最佳管理策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15f0/8039643/0d78a9ad2a7c/atm-09-06-520-f1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验